| Features: Estrogen-like activity |
| Genistein is a naturally occurring isoflavone predominantly found in soy products. -soy isoflavone Anticancer effects through several mechanisms: -Modulation of Hormone Activity: can bind to estrogen receptors(hormone-dependent cancers like breast and prostate cancer). -Inhibition of Cell Proliferation:- -inducing cell cycle arrest. -Induction of Apoptosis:- by influencing pro- and anti-apoptotic regulators. -Anti-inflammatory and Antioxidant Effects:-antioxidant properties help to neutralize ROS -Anti-angiogenic Activity:may also inhibit tumor angiogenesis Key Cellular Signaling Pathways Involved -Estrogen Receptor Signaling: interacting with estrogen receptors (ERα and ERβ) -PI3K/Akt/mTOR Pathway:inhibits this pro-survival pathway, leading to reduced cell growth -MAPK/ERK Pathway: can contribute to cell cycle arrest. -NF-κB Pathway:may downregulate NF-κB, supporting a reduction in tumor-promoting inflammation. -Wnt/β-catenin Pathway: involved in cell proliferation, differentiation, and oncogenic transformation. Dosages often ranging from approximately 40 mg to 100 mg per day for potential therapeutic effects. Genistein has limited bioavailability when ingested as part of the diet. Efforts to enhance its absorption include the use of specific formulations, such as those that combine genistein with other compounds or utilize novel delivery systems. |
| 702- | Bor, | GEN, | SeMet, | Rad, | Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States) |
| - | Analysis, | NA, | NA |
| 24- | EGCG, | GEN, | QC, | Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin |
| - | in-vitro, | Pca, | 22Rv1 |
| 685- | EGCG, | CUR, | SFN, | RES, | GEN | The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein |
| - | Analysis, | NA, | NA |
| 28- | GEN, | Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway |
| - | in-vivo, | BC, | MCF-7 |
| 29- | GEN, | Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway |
| - | in-vivo, | Pca, | NA |
| 927- | GEN, | PacT, | Bioenhancers from mother nature and their applicability in modern medicine |
| - | Review, | Nor, | NA |
| 1435- | GEN, | SFN, | The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF-7 |
| 1504- | GEN, | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
| - | Review, | NA, | NA |
| 2997- | GEN, | Genistein Inhibition of Topoisomerase IIα Expression Participated by Sp1 and Sp3 in HeLa Cell |
| - | in-vitro, | Cerv, | HeLa |
| 2998- | GEN, | Cellular and Molecular Mechanisms Modulated by Genistein in Cancer |
| - | Review, | Var, | NA |
| 4664- | GEN, | CUR, | RES, | EGCG, | SFN | Targeting cancer stem cells by nutraceuticals for cancer therapy |
| - | Review, | Var, | NA |
| 1277- | I3C, | GEN, | Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein |
| - | in-vitro, | PC, | PANC1 |
| 156- | Ralox, | Tam, | GEN, | CUR, | Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:85 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid